Private Equity Deals highlighted Week 24-23

Don’t miss our weekly selection of the Private Equity deals in Europe and North America from the Week 24, extracted from the Arx Database.

Subscribe to our tailored newsletters for industry professionals to follow market trends based on your preferred areas and access all relevant sector news.

For more in-depth information on fund activities in Europe and North America, be sure to sign up.

This week’s Investindustrial, FNB Private Equity, Hig Capital, Ta Associates Management.

Table of Contents

New deal Investindustrial

Add-on: Investindustrial

Arterex Acquires Medical Device Manufacturer NextPhase

Majority-owned by Investindustrial, Arterex (California / USA), a provider of diversified, high-precision manufacturing solutions for the medical device, healthcare, and life sciences industries, acquires NextPhase Medical Devices (Massachusetts / USA), a manufacturer of complex electromechanical medical devices and single-use disposable medical devices. The acquisition of NextPhase will enable Arterex to double in size and become a leading global subcontractor in the field of medical devices, with 70% of its revenue generated in the United States.

Investindustrial, press release

New deal FNB Private Equity

Acquisition: FNB Private Equity

FNB Acquires Organic Coffee Producer Cafés Legal

FNB Private Equity acquires 100% of Cafés Legal (Île-de-France / FRA), producer and distributor of organic coffees in various forms. This is the first acquisition made by FNB Private Equity’s fund, FnB Europe Fund II SP.

Press

New Deal HIG Capital

Exit: HIG Capital

ICIG Acquires Distributor of Hydrocarbon-based Specialty Products HCS Group

International Chemical Investors Group (ICIG) (District of Luxembourg / LUX), a group of companies operating in the fields of chemistry and industry, acquires HCS Group (c. €330 million of revenue in 2021, Hesse / DEU), an international company specializing in the production and distribution of specialty products based on hydrocarbons and solvents. The acquisition was made from HCS Group’s shareholders, including H.I.G. Capital, which has backed the company since 2013.

International Chemical Investors Group, press release

New Deal TA Associates Management

Fundraising: TA Associates Management

TA Associates Raises $16.5 Billion for its Fund TA XV

TA Associates Management raised $16.5 billion for its TA XV fund, surpassing its original target as well as the size of its predecessor, TA XIV, which closed in June 2021 at its hard cap of $12.5 billion. TA XV will be invested in high value-added companies operating in the technology, healthcare, financial services, consumer services and business services sectors.

TA Associates Management, press release

Never miss a deal — subscribe to our weekly intelligence

Join thousands of M&A advisors, PE investors and corporate finance professionals who receive our curated weekly newsletter covering the latest transactions, exits, and market movements across Europe and North America.

Weekly PE deals, add-ons, acquisitions and exits
Coverage across Europe and North America
Curated by our corporate finance analysts
Delivered every week to your professional inbox